I now have sufficient information from the medical library and web sources to compile a comprehensive answer. Let me deliver the full response.
Clinical Scales - Indications, Contraindications, Precautions, Procedure, and Clinical Use
CARDIAC FUNCTIONAL CLASSIFICATION
New York Heart Association (NYHA) Functional Classification
Overview
Developed by the New York Heart Association, this is the most widely used system for grading functional impairment in patients with heart failure (HF). It classifies patients into four classes based on symptoms during physical activity. It is used alongside the ACC/AHA staging system, which classifies the structural progression of disease. The NYHA system focuses specifically on exercise tolerance in those with established HF. - Braunwald's Heart Disease, p. 89
Indications
The NYHA classification is indicated for patients with established or suspected heart failure of any etiology - including HF with reduced ejection fraction (HFrEF), HF with preserved ejection fraction (HFpEF), and HF with recovered EF. It is used to assess symptom severity, guide treatment decisions, determine eligibility for specific therapies (e.g., mineralocorticoid receptor antagonists, cardiac resynchronization therapy, implantable cardioverter-defibrillators), assess prognosis, and monitor disease progression over time. It is also applied in pregnancy with cardiac disease to stratify risk, with NYHA classes I and II carrying considerably better outcomes than III or IV. - Creasy & Resnik's Maternal-Fetal Medicine, p. 6198
Contraindications
There are no absolute contraindications to applying the classification, as it is a clinical observation tool requiring only history-taking. However, it should not be used as the sole determinant for complex management decisions, as it carries considerable subjectivity and does not correlate well with objective measures of cardiac structure. It is not validated as a standalone diagnostic tool.
Precautions
The scale is highly subjective and prone to inter-observer variability. NYHA class does not correlate reliably with other objective measures such as LVEF or natriuretic peptide levels. Patients may underreport symptoms by unconsciously restricting their activities. The classification should always be used in conjunction with objective assessment (echocardiography, BNP/NT-proBNP, exercise testing). It is not ideal for tracking rapid changes in clinical status. - Harrison's Principles of Internal Medicine 22E, p. 2287
Procedure
The classification is assigned through clinical interview and observation. The clinician asks the patient about symptoms - primarily dyspnea, fatigue, palpitations, and angina - in relation to physical exertion levels. No equipment is required.
-
Class I: No limitation of physical activity. Ordinary physical activity does not cause symptoms.
-
Class II: Slight limitation. Comfortable at rest, but ordinary physical activity results in symptoms.
-
Class III: Marked limitation. Comfortable at rest, but less-than-ordinary activity causes symptoms.
-
Class IV: Unable to carry on any physical activity without symptoms, or symptoms present at rest.
-
Braunwald's Heart Disease, Table 48.1
Clinical Use
The NYHA classification guides therapy at every stage of HF management. Class II-IV symptoms trigger consideration of pharmacological optimization (ACE inhibitors, beta-blockers, diuretics). Class III-IV is required for CRT eligibility. Class II-IV with LVEF ≤35% supports ICD referral. The scale is used for patient communication, prognostication, and research enrollment criteria. It also tracks response to treatment over serial assessments. - Braunwald's Heart Disease, p. 2052
ICU AND CRITICAL CARE SCALES
1. Medical Research Council (MRC) Muscle Strength Scale
Overview
Originally developed by the British Medical Research Council in 1943, the MRC scale grades voluntary muscle strength from 0 (no contraction) to 5 (normal strength). In the ICU context, it is used primarily as the MRC Sum Score - the sum of strength across six bilateral muscle groups - to detect and diagnose ICU-acquired weakness (ICUAW). An MRC Sum Score below 48/60 defines ICUAW; a score below 36 indicates severe weakness.
Indications
- Detection and diagnosis of ICU-acquired weakness (ICUAW) in critically ill patients who have been mechanically ventilated for more than 3-7 days
- Monitoring neuromuscular function in patients with critical illness polyneuropathy or myopathy
- Assessing progression of weakness in Guillain-Barré syndrome, myasthenia gravis, and other neuromuscular conditions
- Guiding rehabilitation planning and exercise prescription in the ICU
- Predicting weaning from mechanical ventilation and ICU/hospital length of stay
- Baseline and serial neuromuscular assessment during early mobilization programs
Contraindications
- Patients who are unconscious, heavily sedated (RASS -3 to -5), or unable to follow commands - the standard MRC scale requires active patient participation
- Presence of delirium (assessed using CAM-ICU) invalidates voluntary strength testing
- Focal orthopaedic injuries, fractures, or immobilization devices at the joint being tested
- Peripheral nerve injuries or amputations affecting the limb being assessed
- Hemiplegia after stroke affecting the tested side (score the contralateral or proximal limb if more than two extrapolations are needed, the MRC Sum Score cannot be validly calculated)
Precautions
- The test requires full patient cooperation; a score of 5/5 on five standardized orientation questions or a negative CAM-ICU is required before proceeding with voluntary muscle testing
- Interrater reliability is moderate at individual muscle level but improves significantly for the Sum Score (<48 threshold: kappa 0.68; <36 threshold: kappa 0.93)
- Bed position affects results: for movements against gravity (MRC ≥3), the head of the bed is at 45°; for gravity-eliminated positions (MRC <2), the bed is at 10°
- Results should be interpreted in context of the patient's pain level, fatigue, and medication effects (sedation, neuromuscular blocking agents)
- Half-grades (e.g., 4+, 4-) should be rounded to full numbers: 4+ = 4, 4- = 3, 5- = 4
- If a muscle group cannot be tested, use the contralateral limb's score; if unavailable, use the ipsilateral proximal group. If more than two extrapolations are necessary, the Sum Score is invalid.
Procedure
Six bilateral muscle groups are tested:
- Shoulder abductors
- Elbow flexors
- Wrist extensors
- Hip flexors
- Knee extensors
- Foot dorsiflexors
Each group is graded 0-5 (left and right), giving a maximum total of 60. The grades are:
- Grade 5: Normal strength, movement against maximum resistance
- Grade 4: Movement against gravity and some resistance
- Grade 3: Movement against gravity over full range but no resistance
- Grade 2: Movement with elimination of gravity (gravity-eliminated position)
- Grade 1: Visible contraction without movement of the limb
- Grade 0: No visible contraction
The neurological and hemodynamic stability of the patient must be confirmed by a medical doctor before testing proceeds.
Clinical Use
The MRC Sum Score is the diagnostic standard for ICUAW. A score <48/60 confirms the diagnosis and is associated with prolonged mechanical ventilation, longer ICU and hospital stay, increased mortality, and reduced quality of life in survivors. It predicts functional outcomes at ICU and hospital discharge. In clinical practice, it is performed at ICU awakening and repeated at ICU discharge to track recovery. It also provides input to the PFIT-s testing.
2. ICU Mobility Scale (IMS)
Overview
The IMS is an 11-level (0 to 10) categorical scale measuring the highest functional mobility level achieved by a patient during a given observation period within the ICU. It was developed to provide a hierarchical, ordinal assessment of mobility ranging from passive activities to independent ambulation.
Indications
- Documenting and tracking functional mobility of adult ICU patients throughout their stay
- Guiding early mobilization programs and rehabilitation planning
- Assessing patient readiness for progressive mobility interventions
- Measuring responsiveness to physiotherapy or rehabilitation interventions
- Predicting discharge destination (home vs. facility) at ICU discharge
Contraindications
- Active hemodynamic instability precluding any movement (e.g., active vasopressor titration for shock, life-threatening arrhythmias)
- Unstable fractures or acute orthopaedic injuries that prevent movement of the tested regions
- Severe respiratory failure requiring complete bed rest
- Any medical contraindication to mobilization as determined by the treating team
Precautions
- The IMS demonstrates significant floor effects when used early in the ICU (many patients score 0-1), which limits its ability to differentiate between very low-function patients at awakening
- It measures the highest level achieved, which may not reflect the patient's typical or sustainable function
- Careful safety monitoring is required during any active mobility tasks, including SpO2, heart rate, blood pressure, and patient-reported exertion
- Equipment and staffing requirements increase as level progresses; higher-level tasks (standing, walking) require adequate personnel
Procedure
The scale is scored by observing the highest level of mobility the patient achieves:
- 0: Lying in bed, passive repositioning only
- 1: Sitting in bed (exercises in bed or passive)
- 2: Passively moved to chair (no active participation)
- 3: Sitting over the edge of bed
- 4: Standing (with or without assistance)
- 5: Transferring to chair (walking with assistance)
- 6: Marching on spot (standing with assistance)
- 7: Walking with assistance from 2 or more people
- 8: Walking with assistance from 1 person
- 9: Walking independently with a gait aid
- 10: Walking independently without a gait aid
A single score is recorded representing the highest level achieved within a defined period (typically per therapy session or per day).
Clinical Use
The IMS correlates strongly with MRC Sum Score (rho = 0.57) and FSS-ICU (r = 0.86) at ICU discharge. Higher IMS scores at ICU discharge predict discharge to home. It has good responsiveness to change from ICU awakening to discharge (effect size 0.59). However, its floor effects on awakening limit utility for early differentiation. It is best used as an ongoing mobility tracking tool throughout the ICU stay to document rehabilitation progress and communicate between multidisciplinary team members.
3. Physical Function ICU Test - Scored (PFIT-s)
Overview
The PFIT-s was developed by Skinner et al. (2009) and later refined by Denehy et al. (2013) using principal component analysis and Rasch analysis. It is a 4-component performance-based battery specifically designed for critically ill ICU patients who are too unwell to complete standard exercise tests such as the 6-Minute Walk Test. Scores range from 0 to 10, with higher scores indicating better physical function.
Indications
- Objectively measuring physical function in mechanically ventilated patients (typically ≥4 days of MV) who are alert and able to follow commands
- Guiding exercise prescription within the ICU (including intensity via rate of perceived exertion during marching)
- Assessing functional recovery from ICU awakening through discharge
- Predicting discharge destination (home vs. facility)
- Tracking response to rehabilitation interventions
- Identifying ICU-acquired weakness as part of a functional battery alongside MRC Sum Score
Contraindications
- Patients who cannot follow commands or are heavily sedated (requires RASS 0 or positive, ability to follow instructions)
- Patients who cannot achieve sitting: if unable to sit over edge of bed, only limb muscle testing in bed is possible, and sit-to-stand and marching components cannot be assessed
- Active hemodynamic instability contraindicated for active functional testing
- Orthopaedic restrictions preventing lower limb weight-bearing (affects sit-to-stand and marching components)
- Severe respiratory compromise where any exertion is unsafe
Precautions
- MRC Sum Score and grip strength should be tested before PFIT-s to confirm the patient has sufficient ability to participate; this also reduces duplication since MRC components overlap
- If the patient has limited range of motion, test strength within the available range
- Use the stronger side (right or left) for shoulder flexion and knee extension scoring
- The patient may use a walker during the marching component if required
- If sitting in a chair is possible, use the chair position for all components (preferred over bed-edge sitting)
- No adverse events have been documented during PFIT-s testing in the ICU, but safety monitoring (vital signs, SpO2) should be maintained throughout
- If the patient is in a gravity-eliminated position, maximum grade achievable is 2
Procedure
Four components are assessed in order:
-
Shoulder Flexion Strength: graded 0-5 using MRC criteria; the stronger side is used. Grades 0-2 score 0, grade 3 scores 1, grade 4 scores 2, grade 5 scores 3 on the PFIT.
-
Knee Extension Strength: graded 0-5 using MRC criteria; same conversion applied.
-
Sit-to-Stand Assistance: The patient attempts to stand from a seated position. Assistance level determines score: 0 = unable to stand; 1 = requires 2 people; 2 = requires 1 person; 3 = independent.
-
Marching on the Spot Cadence: The patient marches on the spot for up to 3 minutes. Steps are counted and time is recorded. Cadence = (number of steps / time in seconds) × 60. Score: 0 = unable; 1 = <40 steps/min; 2 = 40-79 steps/min; 3 = ≥80 steps/min or sustained for 3 minutes.
The four component scores are summed using Rasch-converted interval scoring to produce the final PFIT-s score (0-10). The highest score from multiple test attempts is used.
Clinical Use
The PFIT-s has established validity, responsiveness, and predictive utility. It strongly correlates with MRC Sum Score (rho = 0.8) and FSS-ICU (r = 0.85-0.87). Among all ICU functional measures, the PFIT-s demonstrates the highest effect size for responsiveness to change (0.71) from awakening to ICU discharge. Higher scores at awakening predict direct discharge to home. It provides objective data to guide exercise prescription by intensity and can be repeated serially throughout admission. It is safe with no reported adverse events during administration in the ICU setting.
4. Functional Status Score for the ICU (FSS-ICU)
Overview
The FSS-ICU is a 5-item performance-based measure using an 8-point ordinal scale (0-7 per item) to assess physical function in the ICU. It evaluates a hierarchical sequence of functional tasks. The total score ranges from 0 to 35, with higher scores indicating better function. A baseline version can be administered retrospectively by proxy via telephone.
Indications
- Measuring physical function in adult ICU patients across a range of acuity levels, including mechanically ventilated patients
- Tracking functional changes from ICU awakening through ICU discharge
- Evaluating functional recovery as an outcome measure in clinical research
- Predicting discharge destination (home vs. facility) at ICU discharge
- Baseline assessment of pre-ICU functional status (via retrospective proxy version)
Contraindications
- Patients who are fully unconscious or non-cooperative cannot participate in active task performance
- Severe hemodynamic instability preventing any movement or repositioning
- Active surgical precautions or orthopaedic restrictions preventing the specific movement tasks (e.g., no weight-bearing, sternal precautions post-cardiac surgery limit rolling and transfer tasks)
- Note: Post-cardiac surgery patients with drains and infusions may have artificially lower scores due to restricted movement, reducing validity in this specific group
Precautions
- Post-operative drains, catheters, and IV infusions can mechanically restrict movement and result in artificially low scores, reducing the validity of the FSS-ICU in cardiac and major surgical ICU patients
- Floor effect is minimal (<0.5%) but ceiling effect is present at hospital discharge (~21%), limiting sensitivity to improvement in higher-functioning patients
- The scale measures observed performance, not capacity; this should be considered when interpreting results in the context of environmental or equipment restrictions
- Monitoring of vital signs and SpO2 is required during active testing components
Procedure
Five functional tasks are assessed and scored 0-7:
- Rolling (side to side in bed)
- Supine-to-sit transfer (lying to sitting at edge of bed)
- Sitting at edge of bed (unsupported balance)
- Sit-to-stand transfer
- Walking (or ambulation attempt)
Each task is scored on an 8-point scale based on the level of assistance required:
- 0: Unable to perform the activity
- 1: Total assistance (patient performs <25% of the activity)
- 2: Maximal assistance (patient performs 25-49%)
- 3: Moderate assistance (patient performs 50-74%)
- 4: Minimal assistance (patient performs 75-99%)
- 5: Supervision or setup only
- 6: Modified independence (uses equipment)
- 7: Complete independence
Maximum total score is 35. The score reflects the level of physical assistance required rather than the speed or quality of movement.
Clinical Use
The FSS-ICU shows excellent concurrent validity with PFIT-s (r = 0.85-0.87) and MRC Sum Score (r = 0.69) at ICU awakening. At ICU discharge, it correlates excellently with FIM motor domain (r = 0.94) and IMS (r = 0.86). It predicts discharge to home at ICU discharge. It is responsive to change from awakening to discharge (effect size 0.46, small to moderate). The FSS-ICU and PFIT-s are jointly recommended as the most clinically applicable functional measures for ICU use in both clinical practice and research.
5. Glasgow Coma Scale (GCS)
Overview
Published in 1974 by Teasdale and Jennett at the University of Glasgow, the GCS is a neurological scale providing a reliable, objective method of recording the conscious state of a person. It was initially developed for post-head injury assessment but is now applied broadly across all causes of impaired consciousness. It comprises three domains - Eye, Verbal, and Motor - scored separately and summed. Total scores range from 3 (deep coma or death) to 15 (fully awake and oriented). - Parikh's Medical Jurisprudence, p. 6300
Indications
- Initial and serial assessment of level of consciousness following traumatic brain injury (TBI)
- Assessment of consciousness level in any cause of altered mental status (stroke, metabolic encephalopathy, infection, overdose, post-cardiac arrest)
- Triage and severity grading: GCS 14-15 = mild head injury; GCS 9-13 = moderate; GCS 3-8 = severe
- Guiding intubation decisions (GCS ≤8 classically indicates airway protection need)
- Monitoring ICU patients for neurological deterioration or improvement
- Pre- and post-resuscitation neurological status documentation
- Grading subarachnoid hemorrhage severity (Hunt-Hess and WFNS scales incorporate GCS)
- Predicting neurological outcome: the motor score component is the best single predictor of neurological outcome in TBI - Bailey & Love's Surgery, p. 8446
Contraindications
There are no absolute contraindications to assessment. However, valid scoring requires intact peripheral sensorimotor pathways and an undrugged state. The scale cannot be meaningfully applied when:
- Drug-induced sedation or paralytic agents affect all three domains
- Severe orbital trauma prevents eye opening assessment
- Tracheostomy or intubation prevents verbal response (the "T" modifier is used)
- Severe facial trauma prevents verbal assessment
Precautions
- Intubated patients cannot score verbal responses fully; document with the "1T" modifier
- Results are affected by alcohol, sedative medications, neuromuscular blocking agents, and metabolic disturbances (hypoglycemia, hyponatremia)
- The scale should be assessed post-resuscitation (stable airway, oxygenation, and hemodynamics) for valid trauma scoring
- In small children, the Pediatric GCS (modified criteria for developmental stage) should be used
- Individual domain scores (E, V, M) are more informative than the total alone and should always be reported separately
- A normal GCS does not exclude significant intracranial pathology (e.g., extradural hematoma with lucid interval)
Procedure
Three domains are assessed:
Eye Response (E, 1-4):
- 1: No eye opening
- 2: Opens to pain (nail-bed or supraorbital pressure)
- 3: Opens to speech (not sleep-awakening; that scores 4)
- 4: Eyes open spontaneously
Verbal Response (V, 1-5):
- 1: No verbal response
- 2: Incomprehensible sounds (moaning)
- 3: Inappropriate words (random speech, no conversation)
- 4: Confused (coherent but disoriented)
- 5: Oriented (knows name, place, date)
Motor Response (M, 1-6):
- 1: No motor response
- 2: Extension to pain (decerebrate posturing)
- 3: Abnormal flexion to pain (decorticate posturing)
- 4: Withdrawal from pain
- 5: Localizes pain
- 6: Obeys commands
Total GCS = E + V + M (range 3-15). Apply pain stimuli centrally (supraorbital, trapezius squeeze) first; use peripheral (nail bed) for differentiation. Document each domain score individually plus the total.
Clinical Use
The GCS is the global standard for consciousness monitoring. The motor subscore is the most robust predictor of neurological outcome in TBI. Serial assessment detects clinical deterioration - a drop of 2 or more points is clinically significant. It guides management (e.g., intubation threshold, ICP monitoring indication, ICU admission criteria, neurosurgical consultation). The Washington Manual states it provides "semiquantitative assessment" of consciousness that can be followed over time. It is incorporated into severity-of-illness scoring systems including APACHE II and SOFA. - Washington Manual, p. 1675
FUNCTIONAL INDEPENDENCE SCALES
1. Barthel Index (BI)
Overview
The Barthel Index is one of the most widely used clinician-rated scales for assessing activities of daily living (ADL). It evaluates 10 basic functional domains. Scoring ranges from 0 (total dependence) to 100 (complete independence), though some versions use a 0-20 scale. It was originally developed for stroke rehabilitation but is now applied broadly across neurological, orthopaedic, and geriatric conditions. - Adams and Victor's Neurology, p. 2182
Indications
- Assessing baseline functional independence in patients with neurological, orthopaedic, or general physical impairments
- Measuring functional outcomes after stroke, spinal cord injury, TBI, hip fracture, and other disabling conditions
- Monitoring rehabilitation progress over time
- Discharge planning and determination of care needs (home vs. facility)
- Benchmarking outcomes in clinical trials (used as a primary outcome in many stroke trials)
- Most appropriate for individuals with significant physical or cognitive impairments - Kaplan & Sadock's Psychiatry, p. 2633
Contraindications
There are no absolute contraindications. The BI is not appropriate as the only functional measure in high-functioning individuals (ceiling effect) or in patients with only mild disability, as it may not detect meaningful changes. It is less sensitive for detecting subtle functional changes in cognitively impaired patients who may perform differently in clinic vs. home environments.
Precautions
- Significant ceiling effects in patients who are more functional - they may score 100 but still have meaningful deficits in instrumental ADLs (IADLs) or community function
- The scale scores basic ADL capacity and does not assess cognitive, communicative, or community function
- Point scoring is variable across items and emphasizes transfers, mobility, and toileting over other domains
- Scores obtained in clinical settings may not reflect performance in the patient's home environment
- Should be supplemented by the FIM, FAM, or community-function measures when a fuller picture is needed
Procedure
The clinician rates each of the following 10 items on a Likert-type scale from dependent (0) to independent:
- Feeding (0, 5, or 10)
- Bathing (0 or 5)
- Grooming (0 or 5)
- Dressing (0, 5, or 10)
- Bowel movements (0, 5, or 10)
- Bladder control (0, 5, or 10)
- Toilet use (0, 5, or 10)
- Transfers (bed to chair and back) (0, 5, 10, or 15)
- Mobility on level surfaces (0, 5, 10, or 15)
- Stair use (0, 5, or 10)
Scoring interpretation:
- 0-20: Total dependence
- 21-60: Severe dependence
- 61-90: Moderate dependence
- 91-99: Minimal dependence
- 100: Complete independence (for basic ADLs only)
Behavioral anchors are provided for midpoint scores (e.g., for transfers, a score of 5 indicates major help from 1 or 2 people).
Clinical Use
The Barthel Index is the standard ADL outcome measure in stroke trials. A single point change represents a clinically meaningful difference. It has been validated for use in TBI, spinal cord injury, hip fracture, and multiple conditions beyond stroke. The 0-100 version and 0-20 version are both in use; the version used should always be specified. In the acute post-ICU phase, the BI is used alongside the PFIT-s and 6MWT to track recovery of ADL independence. - Adams and Victor's Neurology, p. 2182
2. Functional Independence Measure (FIM)
Overview
The FIM is an 18-item clinician-rated assessment widely used in rehabilitation settings to measure functional dependence and independence. Each item is rated on a 7-point scale (1 = total assistance to 7 = complete independence), with scores ranging from 18 (total dependence) to 126 (complete independence). The FIM measures observed performance, not capacity. It features two domains: 13 motor items and 5 cognitive items. Rater certification is required (80% accuracy threshold through the Uniform Data System for Medical Rehabilitation). - Kaplan & Sadock's Psychiatry, p. 2635-2636
Indications
- Determining the level of functional dependence/independence in patients in inpatient rehabilitation settings
- Measuring rehabilitation outcomes in TBI, stroke, spinal cord injury, and other disabling conditions
- Tracking functional change over the course of an inpatient rehabilitation stay
- Calculating burden of care (more total assistance = higher burden)
- Predicting length of inpatient rehabilitation stay and discharge destination
- Research outcome measurement across rehabilitation populations
Contraindications
- The FIM rates observed performance, not capacity; it is less valid in inpatient settings with high levels of observation where the patient's actual everyday performance is seen rather than a standardized assessment
- Should not be used as the sole outcome measure for community-dwelling patients where IADLs and participation-level function are more relevant
- Patients in acute ICU phases with minimal ability to cooperate cannot be fully assessed on all 18 items
Precautions
- Trained and certified raters are required for standardized administration; uncertified raters produce less reliable scores
- The FIM does not capture community or instrumental activities; the FAM must be added to address these domains
- Motor and cognitive subscores should be reported separately; the total score blends functionally distinct domains
- The scale has well-documented floor and ceiling effects at the extreme ends of function
- Environmental adaptations (equipment, home modifications) are not distinguished from true independence
Procedure
The FIM's 18 items are divided into:
Motor Domain (13 items): self-care (eating, grooming, bathing, dressing upper body, dressing lower body, toileting), sphincter management (bladder and bowel), transfers (bed/chair/wheelchair, toilet, tub/shower), locomotion (walking/wheelchair, stairs)
Cognitive Domain (5 items): comprehension, expression, social interaction, problem solving, memory
Each item is scored 1-7:
- 7: Complete independence (timely, safely, no helper)
- 6: Modified independence (device used)
- 5: Supervision or setup only
- 4: Minimal assistance (patient performs ≥75%)
- 3: Moderate assistance (patient performs 50-74%)
- 2: Maximal assistance (patient performs 25-49%)
- 1: Total assistance (patient performs <25%)
The clinician observes the patient's actual performance in the clinical or rehabilitation environment. Score the lowest level of independence observed.
Clinical Use
The FIM is the most widely used functional assessment in inpatient rehabilitation worldwide. It predicts length of inpatient rehabilitation stay, discharge destination, and rehabilitation resource needs. A FIM motor gain of approximately 3.5 points per day is a benchmark for active rehabilitation. Higher admission FIM scores correlate with better discharge outcomes. It feeds into the Uniform Data System for Medical Rehabilitation national database, enabling benchmarking across facilities. In the acute post-ICU phase, FIM motor scores correlate strongly with FSS-ICU (r = 0.94), making it a useful bridge measure as patients transition from ICU to rehabilitation. - Bradley & Daroff's Neurology, p. 2290
3. Functional Assessment Measure (FAM)
Overview
The FAM was specifically created to supplement the FIM and extend its scope. It adds 12 additional items focused on cognitive, behavioral, communication, and community functioning. The FIM + FAM combined instrument comprises 30 items and spans a score range of 30-210. Both scales were originally designed for brain injury rehabilitation but are widely applied to older adults and other populations in rehabilitation. - Kaplan & Sadock's Psychiatry, p. 2641
Indications
- Supplementing the FIM to capture cognitive, behavioral, and community domains that the FIM alone does not address
- Comprehensive evaluation of individuals with TBI, stroke, or acquired brain injury in inpatient and transitional rehabilitation settings
- Measuring functional change over the course of inpatient rehabilitation when cognitive and community dimensions are clinically relevant
- Evaluating older adults in rehabilitation settings where cognitive and social function are important outcomes
- Research in brain injury rehabilitation where a more complete functional profile is required
Contraindications
- Should not be used independently from the FIM, as the FAM was designed as a supplement, not a standalone instrument
- Patients with severe communication impairment or profound cognitive impairment may be unable to be rated accurately on all 12 FAM items
- Not indicated when the primary concern is basic motor ADLs only (the FIM alone suffices in those cases)
Precautions
- The FIM + FAM is a 30-item battery; administration is more time-intensive than the FIM alone and requires a trained rater
- Inter-rater reliability varies across FAM items; cognitive and behavioral items require experienced clinical judgment
- The FAM items use the same 7-point FIM scale, so rater certification for the FIM is a prerequisite
- Community and instrumental function items may be difficult to assess accurately in an inpatient or restricted clinical environment
Procedure
The FAM's 12 additional items include:
- Community functioning: community access, car transfers, reading, writing, speech intelligibility, employability, orientation, attention, safety judgment, concentration
- Behavioral/emotional: emotional status, adjustment to limitations
All 12 items are rated on the same 7-point FIM scale (1 = total assistance to 7 = complete independence). The FAM is administered immediately following the FIM using the same observation period. The combined FIM + FAM score (30-210) is the primary composite output.
Clinical Use
The FIM + FAM provides a more complete functional profile for patients with TBI and acquired brain injury than the FIM alone, capturing the cognitive and community reintegration challenges that are central to recovery in this population. It is used to evaluate change over the course of inpatient rehabilitation stays and to inform discharge planning, particularly regarding readiness for community living. It has been validated for TBI and is widely adopted in both brain injury-specific and general rehabilitation units that treat older adults.
Summary of Key Scoring Ranges
NYHA: I-IV (class-based, no numeric total) | MRC Sum Score: 0-60 (ICUAW <48, severe <36) | IMS: 0-10 (higher = more mobile) | PFIT-s: 0-10 (higher = better function) | FSS-ICU: 0-35 (higher = more independent) | GCS: 3-15 (3 = deep coma, 15 = normal) | Barthel Index: 0-100 (0 = total dependence, 100 = independent in basic ADLs) | FIM: 18-126 (18 = total dependence, 126 = full independence) | FIM + FAM: 30-210